| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.
|
Eur Heart J
|
2005
|
3.50
|
|
2
|
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
|
Am J Med
|
2013
|
3.46
|
|
3
|
State of the art: using natriuretic peptide levels in clinical practice.
|
Eur J Heart Fail
|
2008
|
3.35
|
|
4
|
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2007
|
2.46
|
|
5
|
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
|
Am J Cardiol
|
2006
|
2.37
|
|
6
|
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
|
J Am Coll Cardiol
|
2010
|
2.25
|
|
7
|
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.
|
Circulation
|
2010
|
1.73
|
|
8
|
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.
|
Eur J Heart Fail
|
2011
|
1.61
|
|
9
|
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
|
J Am Coll Cardiol
|
2008
|
1.60
|
|
10
|
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
|
Crit Care Med
|
2011
|
1.45
|
|
11
|
QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
|
Cardiology
|
2006
|
1.42
|
|
12
|
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
|
Circ Heart Fail
|
2010
|
1.27
|
|
13
|
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
|
Eur J Heart Fail
|
2009
|
1.25
|
|
14
|
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
|
J Am Coll Cardiol
|
2007
|
1.18
|
|
15
|
Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.
|
Clin Res Cardiol
|
2008
|
1.15
|
|
16
|
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
|
Eur Heart J
|
2012
|
1.08
|
|
17
|
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
|
Circ Heart Fail
|
2011
|
1.05
|
|
18
|
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
|
Am Heart J
|
2009
|
1.04
|
|
19
|
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.
|
J Am Soc Hypertens
|
2010
|
1.04
|
|
20
|
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
|
Eur J Heart Fail
|
2013
|
1.04
|
|
21
|
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
|
Eur J Heart Fail
|
2010
|
1.02
|
|
22
|
Cachexia: common, deadly, with an urgent need for precise definition and new therapies.
|
Am J Cardiol
|
2008
|
1.02
|
|
23
|
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
|
Eur Heart J
|
2012
|
1.02
|
|
24
|
Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
|
J Am Coll Cardiol
|
2011
|
1.01
|
|
25
|
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
|
Am Heart J
|
2009
|
0.98
|
|
26
|
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1.
|
PLoS One
|
2011
|
0.97
|
|
27
|
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
|
Eur J Heart Fail
|
2012
|
0.93
|
|
28
|
Takotsubo and Kounis syndrome: is there any association?
|
Circ J
|
2007
|
0.93
|
|
29
|
Effect of serum insulin on the association between hyperuricemia and incident heart failure.
|
Am J Cardiol
|
2010
|
0.92
|
|
30
|
Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.
|
Clin Res Cardiol
|
2008
|
0.91
|
|
31
|
Atrial fibrillation in chronic non-cardiac disease: where do we stand?
|
Int J Cardiol
|
2008
|
0.90
|
|
32
|
Ultrafiltration in heart failure with cardiorenal syndrome.
|
N Engl J Med
|
2013
|
0.89
|
|
33
|
Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient?
|
Int J Cardiol
|
2006
|
0.88
|
|
34
|
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
|
Heart Fail Rev
|
2009
|
0.88
|
|
35
|
Uric acid elevation in atrial fibrillation.
|
Hellenic J Cardiol
|
2010
|
0.88
|
|
36
|
Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
|
Eur J Heart Fail
|
2011
|
0.86
|
|
37
|
European Resuscitation Council guidelines for resuscitation 2005. Section 5. Initial management of acute coronary syndromes.
|
Resuscitation
|
2005
|
0.86
|
|
38
|
Digoxin for the treatment of chronic and acute heart failure syndromes.
|
Acute Card Care
|
2009
|
0.85
|
|
39
|
Short-term mortality risk in emergency department acute heart failure.
|
Acad Emerg Med
|
2011
|
0.84
|
|
40
|
First human implantation of a new rotary blood pump: design of the clinical feasibility study.
|
Hellenic J Cardiol
|
2007
|
0.83
|
|
41
|
Prevalence of paroxysmal atrial fibrillation in Brugada syndrome: a case series and a review of the literature.
|
J Cardiovasc Med (Hagerstown)
|
2007
|
0.83
|
|
42
|
Drug-induced long QT syndrome.
|
Hellenic J Cardiol
|
2007
|
0.81
|
|
43
|
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Am Coll Cardiol
|
2017
|
0.81
|
|
44
|
Neurally mediated susceptibility in individuals with Brugada-type ECG pattern.
|
Pacing Clin Electrophysiol
|
2008
|
0.80
|
|
45
|
Noninvasive ventilation in acute cardiogenic pulmonary edema.
|
N Engl J Med
|
2008
|
0.80
|
|
46
|
Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling.
|
Hellenic J Cardiol
|
2008
|
0.80
|
|
47
|
[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].
|
Ital Heart J Suppl
|
2005
|
0.80
|
|
48
|
Prevalence of Brugada sign in a Greek tertiary hospital population.
|
Europace
|
2007
|
0.79
|
|
49
|
Japanese-Western consensus meeting on biomarkers.
|
Int Heart J
|
2011
|
0.79
|
|
50
|
Enterovirus-induced fulminant myocarditis and hemophagocytic syndrome.
|
J Infect
|
2006
|
0.79
|
|
51
|
[Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology].
|
Kardiol Pol
|
2005
|
0.78
|
|
52
|
Recommendations for the structure, organization, and operation of intensive cardiac care units.
|
Eur Heart J
|
2005
|
0.78
|
|
53
|
The use of B-type natriuretic peptides in the intensive care unit.
|
Congest Heart Fail
|
2008
|
0.78
|
|
54
|
B-type natriuretic peptide serum levels in acute heart failure.
|
Eur Heart J
|
2004
|
0.78
|
|
55
|
Myocardial infarction and ventricular septal rupture caused by myocardial bridging.
|
Eur J Cardiothorac Surg
|
2004
|
0.78
|
|
56
|
The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea.
|
Biomarkers
|
2012
|
0.78
|
|
57
|
Left ventricular assist device as a bridge to surgery in postinfarction ventricular septal defect.
|
J Thorac Cardiovasc Surg
|
2008
|
0.77
|
|
58
|
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
|
Am J Ther
|
2008
|
0.77
|
|
59
|
Recurrent syncope associated with a distinct ECG pattern consisting of short QT interval, early repolarization and atrioventricular block.
|
Clin Res Cardiol
|
2009
|
0.77
|
|
60
|
Standardized reporting criteria for studies evaluating suspected acute heart failure syndromes in the emergency department.
|
J Am Coll Cardiol
|
2012
|
0.76
|
|
61
|
Acute heart failure syndromes: epidemiology, risk stratification and prognostic factors.
|
Acute Card Care
|
2009
|
0.76
|
|
62
|
Recommendations on sub-speciality accreditation in cardiology: The Coordination Task Force on Sub-speciality Accreditation of the European Board for the Speciality of Cardiology.
|
Eur Heart J
|
2007
|
0.76
|
|
63
|
Potential-guided versus anatomic-guided approach for slow pathway ablation of the common type atrioventricular nodal reentry tachycardia: a randomized study.
|
Acta Cardiol
|
2009
|
0.76
|
|
64
|
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Card Fail
|
2017
|
0.75
|
|
65
|
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design.
|
Heart Fail Rev
|
2008
|
0.75
|
|
66
|
Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.
|
Can J Cardiol
|
2009
|
0.75
|
|
67
|
Primary antiphospholipid syndrome and factor V Leiden mutation in a young patient with non-bacterial thrombotic endocarditis and transient ischemic stroke.
|
Thromb Haemost
|
2005
|
0.75
|
|
68
|
Exhaled breath condensate in acute and chronic heart failure: new insights into the role of lung injury and barrier dysfunction.
|
Am J Respir Crit Care Med
|
2014
|
0.75
|
|
69
|
Long QT: the chicken or the egg.
|
Resuscitation
|
2003
|
0.75
|
|
70
|
Acute heart failure syndromes: the role of vasopressin antagonists.
|
Acute Card Care
|
2009
|
0.75
|
|
71
|
Severe anaemia and subcapital femur fracture in a patient with Left Ventricular Assist Device Heart Mate II: the cardiologist's management of this rare patient.
|
Eur J Heart Fail
|
2009
|
0.75
|
|
72
|
Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial.
|
Emerg Med J
|
2012
|
0.75
|
|
73
|
Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction.
|
Am J Cardiol
|
2008
|
0.75
|
|
74
|
[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].
|
Rev Esp Cardiol
|
2005
|
0.75
|